Abstract: A tetrahydropyridine derivative having substituents on three rings represented by the following formula (1): ##STR1## (wherein A represents sulfur atom, sulfoxide group or sulfone group; R.sub.1 represents an amino group substituted with a specific substituent or a specific aliphatic oxy group; R.sub.2 and R.sub.3 each represents hydrogen atom or a hydroxy group; and m and n are each an integer of from 0 to 4; provided that when m and n are 2 or above, R.sub.2 's and R.sub.3 's may be either the same or different from each other respectively, that when A is sulfur atom and R.sub.1 is cyclohexylamino group and R.sub.2 is hydrogen atom, R.sub.3 is hydroxy group, that when A is sulfoxide group and R.sub.1 is cyclohexylamino group or 4-hydroxycyclohexylamino group, R.sub.2 is hydrogen atom and R.sub.3 is hydrogen atom or hydroxy group and that when A is sulfone group and R.sub.1 is cyclohexylamino group, R.sub.2 and R.sub.

Abstract: This invention relates to novel pyridine derivatives and 1,2,3,4-tetrahydropyridine derivatives shown by following general formula (I) or (II) and salts thereof which are useful as psychotropic medicaments: ##STR1## wherein A is S or O; R.sub.1 represents an unsubstituted or substituted alkoxy, amino, hydrazino, or 6- or 7-membered heterocyclic group having one or two nitrogen atoms with the proviso that R.sub.1 is not an alkoxy group in formula (I); R.sub.2 and R.sub.3 each represents a hydrogen atom or an unsubstituted or substituted alkyl, aryl, alkenyl, acyl, arylcarbonyl group; and m and n each represents an integer of from 0 to 4.